Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03334292 · ClinicalTrials.gov registry record
Natural History of Wilson Disease
A clinical trial of Wilson Disease, sponsored by Yale University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 6
- Study locations
NCT03334292 is a study of Wilson Disease that is actively recruiting participants, run by Yale University. The registered enrollment target is 300 participants, above the 52-participant average among 4 other Wilson Disease trials with a reported enrollment target (477% higher). The trial reports 6 study locations across 6 states.
The verdict
NCT03334292, a study of Wilson Disease, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to determine the optimal testing for diagnosis and parameters for monitoring treatment of WD that will aid product utilization and development.
Conditions Studied
Study Locations (6)
Connecticut
- Yale University - New Haven
Florida
- Advent Health - Orlando
Texas
- Baylor College of Medicine - Houston
Washington
- Seattle Children's Hospital - Seattle
Other
- Universitätsklinikum Heidelberg - Heidelberg
Surrey
- Royal Surrey Country Hospital - Guildford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-12-18 |
| Est. Completion | 2029-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03334292
The ClinicalTrials.gov registry entry for NCT03334292 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 52-participant average among 4 other Wilson Disease trials with a reported enrollment target (477% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wilson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03334292 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Connecticut, Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT03334292 about?
NCT03334292 is a clinical study titled "Natural History of Wilson Disease". The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to determine the optimal testing for diagnosis and parameters for monitoring treatment of WD that will aid product util...
What is the current status of trial NCT03334292?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2017-12-18. Estimated completion is 2029-11-15.
What conditions does trial NCT03334292 study?
This clinical trial studies the following conditions: Wilson Disease.
Who is sponsoring clinical trial NCT03334292?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03334292 being conducted?
This trial has 6 study locations across Connecticut, Florida, Texas, Washington, Surrey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wilson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
RECRUITING
-
Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study
RECRUITING
-
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
ACTIVE NOT RECRUITING · Phase 1
-
The Assessment of Copper Parameters in Wilson Disease Participants on Standard of Care Treatment
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.